180 related articles for article (PubMed ID: 22464953)
1. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
Sabbagh JJ; Kinney JW; Cummings JL
Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Alzheimer's disease therapeutics.
Rafii MS
J Alzheimers Dis; 2014; 42 Suppl 4():S545-9. PubMed ID: 25079804
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: clinical trials and drug development.
Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
[TBL] [Abstract][Full Text] [Related]
4. A new proposal for randomized start design to investigate disease-modifying therapies for Alzheimer disease.
Zhang RY; Leon AC; Chuang-Stein C; Romano SJ
Clin Trials; 2011 Feb; 8(1):5-14. PubMed ID: 21335586
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
Chabrier PE
Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.
Yaffe K; Tocco M; Petersen RC; Sigler C; Burns LC; Cornelius C; Khachaturian AS; Irizarry MC; Carrillo MC
Alzheimers Dement; 2012 May; 8(3):237-42. PubMed ID: 22546356
[TBL] [Abstract][Full Text] [Related]
7. Rethinking Alzheimer's disease therapy: are mitochondria the key?
Ankarcrona M; Mangialasche F; Winblad B
J Alzheimers Dis; 2010; 20 Suppl 2():S579-90. PubMed ID: 20463405
[TBL] [Abstract][Full Text] [Related]
8. Early clinical trials in Alzheimer's disease: selection and evaluation of drug candidates.
Reines SA
Prog Clin Biol Res; 1989; 317():1283-90. PubMed ID: 2690095
[TBL] [Abstract][Full Text] [Related]
9. Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine.
Flood DG; Marek GJ; Williams M
Biochem Pharmacol; 2011 Jun; 81(12):1422-34. PubMed ID: 21295552
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
Fan LY; Chiu MJ
Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
[TBL] [Abstract][Full Text] [Related]
11. The contribution of transgenic and nontransgenic animal models in Alzheimer's disease drug research and development.
Mhillaj E; Cuomo V; Mancuso C
Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):95-111. PubMed ID: 28177983
[TBL] [Abstract][Full Text] [Related]
12. Targeting p38 MAPK pathway for the treatment of Alzheimer's disease.
Munoz L; Ammit AJ
Neuropharmacology; 2010 Mar; 58(3):561-8. PubMed ID: 19951717
[TBL] [Abstract][Full Text] [Related]
13. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
[TBL] [Abstract][Full Text] [Related]
14. When will Alzheimer's disease be cured? A pharmaceutical perspective.
Townsend M
J Alzheimers Dis; 2011; 24 Suppl 2():43-52. PubMed ID: 21368375
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in Alzheimer's disease drug development.
Cummings JL
Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
[TBL] [Abstract][Full Text] [Related]
16. Searching for new animal models of Alzheimer's disease.
Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
[TBL] [Abstract][Full Text] [Related]
17. Coxibs and Alzheimer's disease: should they stay or should they go?
Firuzi O; Praticò D
Ann Neurol; 2006 Feb; 59(2):219-28. PubMed ID: 16402383
[TBL] [Abstract][Full Text] [Related]
18. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development.
Arendash GW
J Alzheimers Dis; 2012; 32(2):243-66. PubMed ID: 22810103
[TBL] [Abstract][Full Text] [Related]
19. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
20. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
Haas C
J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
